跳至主要内容
临床试验/NCT03750435
NCT03750435Unknown不适用

ZERO Radiation Exposure for Catheter Ablation of Atrial Fibrillation or Left Atrial Tachycardia

Royal Brompton & Harefield NHS Foundation Trust2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2018年10月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
25
试验地点
2
主要终点
Safety of the zero AF procedure

研究概览

简要总结

Atrial fibrillation is the most common arrhythmia but can be treated by a catheter procedure where specialized wires (so-called catheters) are inserted in the left upper heart chamber. This requires crossing the wall between the right and left atrium with a long needle (a so-called transseptal puncture or TSP). This is typically done using x-ray guidance or echo to check if the needle is in the right position. The investigators developed a method to do the TSP without x-rays using a specialized needle that can be also shown as a little icon on the 3D electroanatomical mapping system (CARTO).3D mapping systems are routinely used to track the location of the catheters in cath labs worldwide, but the position of the needle was not tracked yet. The investigators seek to demonstrate that these procedures can be carried out safely, successfully and in a reproducible fashion without any radiation by taking advantage of "faking" the isolated tip of the needle as a catheter on the 3D mapping system. The results will be compared with historic procedures done by the same operator in the years 2012-2017.

详细描述

The hypothesis is that patients who undergo one or more TSP(s) for atrial fibrillation or left atrial tachycardia can be studied without the use of fluoroscopy which should result in a low or ZERO overall radiation exposure for the entire ablation procedure. The investigators will assess the feasibility, safety and efficacy of this new approach.

The patient will be admitted in hospital as for a standard procedure and discharged the next day. Before admission, the patient undergoes a CMR/CT scan (routine in our centre). To avoid total radiation CMR would be preferred, if possible.

The technique of the TSP and the use of the RF needle is commonly used worldwide. The ability to visualize the needle tip on the 3D electroanatomical mapping system facilitates the procedure. The additional visualization by TOE helps to assure that the fossa ovalis has been correctly identified.

After the TSP, the ablation procedure itself will be carried out as conventionally performed using the catheter visualization on the 3D mapping system.

An ECG and an echocardiogram are performed before discharge (as standard care).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any type of atrial fibrillation or left atrial tachycardia
  • Able to give written informed consent
  • Age >18 years old and ≤ 80 years
  • Fulfill established clinical criteria for catheter ablation of atrial fibrillation (1)
  • No evidence of significant structural heart disease or congenital heart disease

排除标准

  • Intolerance or unwillingness to oral anticoagulation with Warfarin
  • Bleeding disorder
  • Contraindication to CT scan
  • Presence of intracardiac thrombus
  • Vascular disorder preventing access to femoral veins
  • Cardiac congenital abnormality
  • Severe, life threatening non-cardiac disease
  • Active malignant disease and recent (<5 years) malignant disease
  • Presence of ASD or PFO closure device
  • Unable or unwilling to comply with F/U requirements
  • Renal impairment
  • Pregnancy

研究组 & 干预措施

Ablation for AF or left-sided AT

Experimental

The patient will be admitted in hospital as for a standard ablation procedure and discharged the next day. The procedure will be carried out without using fluoroscopy and relying on the visualization of the electroanatomical mapping system.

干预措施: AF ablation or left-sided AT ablation (Procedure)

结局指标

主要结局

Safety of the zero AF procedure

时间窗: 6 months

Absence of acute adverse events due to the use of non-fluoroscopic AF ablation • Evidence of chronic adverse events due to the use of non-fluoroscopic catheter ablation during the 6 months F/U period

Feasibility and efficacy

时间窗: 6 months

Assessment on efficacy of non-fluoroscopic AF acutely and if recurrences in 6 months follow up

次要结局

  • Recurrences(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Non-fluoroscopy Ablation of AF/AT | 临床试验